glp-1 agonists and anesthesia New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review Perioperative management of patients taking

Evaluation of a screening system for obesogenic compounds: screening of endocrine disrupting compounds and evaluation of the PPAR dependency of the effect

Our focus on precision manufacturing and strict quality standards ensures reliable products for advanced research applications

P.VeguntaR.VeguntaR.et al

These mature marks typically prove more challenging to treat, making early intervention crucial

Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world data

Psychological Health, Well-Being, and the Mind-Heart-Body Connection: AHA Scientific Statement